The role of synthetic slings in male stress incontinence. by Crites, Melanie A et al.
UC Irvine
UC Irvine Previously Published Works
Title
The role of synthetic slings in male stress incontinence.
Permalink
https://escholarship.org/uc/item/1j60v1h5
Journal
Arab journal of urology, 9(2)
ISSN
2090-598X
Authors
Crites, Melanie A
Sorial, Andrew
Ghoniem, Gamal M
Publication Date
2011-06-01
DOI
10.1016/j.aju.2011.06.011
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Arab Journal of Urology (2011) 9, 129–134Arab Journal of Urology
(Official Journal of the Arab Association of Urology)
www.sciencedirect.comURODYNAMICS/FEMALE UROLOGY
ORIGINAL ARTICLEThe role of synthetic slings in male stress incontinence
Melanie A. Crites a, Andrew Sorial a, Gamal M. Ghoniem a,b,*a Department of Urology, Section Voiding Dysfunction, Urodynamics and Female Urology,
Cleveland Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, FL 33331, USA
b University of California – Irvine Medical Center, 333 City Blvd. West, Ste 2100, Orange, CA 92868, USAReceived 19 April 2011, Received in revised form 24 May 2011, Accepted 8 June 2011
Available online 3 August 201120
ho
Pe
do
*
C
U
EKEYWORDS
Synthetic;
Male slings;
Sphincteric incompetence;
Urinary incontinence
ABBREVIATIONS
MUP, maximal urethral
pressure; DO, detrusor over-
activity; BAMS, bone-
anchor male sling; TOMS,
transobturator male sling;
PGII, Patient Global
Impression of Improvement;
(S)UI, (stress) urinary
incontinence; UBA, urethral
bulking agent; AUS, artificial
urinary sphincter; UDS,
urodynamic study90-598X ª 2011 Arab Ass
sting by Elsevier B.V. All rig
er review under responsibilit
i:10.1016/j.aju.2011.06.011
Corresponding author at: U
enter, 333 City Blvd. West,
SA. Tel.: +714 456 5378; fax
-mail address: gghoniem@uociation
hts reser
y of Arab
niversity
Ste 2100
: +714 4
ci.edu (GAbstract Objective: Our primary aim was to compare the outcomes of synthetic bone-anchored
male slings (BAMS) and transobturator male slings (TOMS), to identify preoperative risk factors
for failure, and to evaluate patient satisfaction with each procedure.
Patients and methods: Charts were reviewed retrospectively of patients who underwent synthetic
BAMS or TOMS from 2000 to 2011. Data were categorised into groups based on outcomes of
‘dry’, ‘improved’ and ‘failure’. Success was defined as completely dry or an improvement by
>50% in daily pad use. The data analysed included demographics, daily pad use before and after
surgery, previous urethral insult, type of prostatectomy, and urodynamic study variables. Data were
analysed using logistical regression, the t-test and chi-square analysis, where appropriate.
Results: Sixty-eight men were analysed (30 in each group; eight patients were excluded). Daily pad
use for the TOMS group changed from 3.5 before to 1.5 after surgery (P= 0.001), whilst the
BAMS group was unchanged from 3.9 to 3.5 (P= 0.747). The TOMS group had a success rate
of 23/30 (77%) and a mean (SD) patient global impression of improvement score of 1.67 (0.90),
whilst the BAMS group had a success rate of 11/30 (37%) and mean (SD) score of 2.64 (1.12). Ure-
thral insult (P= 0.001) and preoperative pad use (P= 0.047) were significant predictors of failure.
Conclusion: TOMS gave better outcomes than BAMS in both performance and patient satisfac-
tion. Patients with a greater severity of incontinence and evidence of urethral insult before surgery
should be counselled about the likelihood of suboptimal outcomes with any type of sling placement.
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Stress urinary incontinence (SUI) is a condition that affects
manymen after prostate surgery, and it negatively impacts theirProduction and hosting by Elsevier
130 Crites et al.health, both physically and emotionally. SUI is most commonly
a result of treatment for prostate cancer, and less commonly
from surgical treatment of benign prostatic hypertrophy
(BPH). In reviewing post-prostatectomy urinary continence
rates at six months post-operative status, robotic assisted lapa-
roscopic prostatectomy achieved continence rates ranging from
82% to 97%, laparoscopic prostatectomy achieved 73–96%,
and open prostatectomy achieved 58–98.5% [1].
Several treatment options exist to facilitate the achievement
of urinary continence. Non-surgical methods include Kegel
exercises and pelvic floor biofeedback to strengthen the pelvic
floor musculature. Injection of urethral bulking agents (UBA),
aminimally invasive procedure, can also be used alone or to aug-
ment urethral bulk after male perineal sling placement. How-
ever, this has proven to have widely varying, and often times
disappointing, results from2.5%to87%efficacy [2,3].Male per-
ineal sling and artificial urinary sphincter (AUS) are the more
invasive surgical options that exist with AUS remaining the
‘‘gold standard’’. Many patients with only minimal or moderate
SUI after prostatectomy find any leakage unacceptable and seek
AUS placement whilst others shy away from AUS placement
secondary to its invasive nature and potential for mechanical
malfunction over time. These same patients may also only show
minimal benefit from injection of UBA’s or non-pharmacologic
means of SUI treatment. It is in these patients that the male per-
ineal sling is the most supportive to the urethra and effective in
its results. Synthetic male slings are minimally invasive, boast
a shorter operative time, hospital stay, and recovery period.
Additionally, patients suffer fewer complications. Simply stated,
it is a procedure that is a quick and relatively simple treatment
modality for the treatment of post-prostatectomy male SUI [4].
The male sling offers a treatment option for male SUI that
requires little from the patient except compliance with the heal-
ing period requiring limited activity and lifting [5]. The greatest
challenge is to find the most effective treatment method for
SUI that simultaneously meets or exceeds patient expectations.
The aim of this study is to compare the outcomes of two syn-
thetic male sling types, bone anchored male sling (BAMS) and
transobturator male slings (TOMS). Secondarily, we aim to
evaluate patient satisfaction with each type of sling procedure.
Patients and methods
Following Internal Review Board approval, a retrospective
chart review was conducted of all male patients having under-
gone synthetic BAMS or TOMS placement for the treatment
of male SUI from 2000 to 2011. Follow-up time was calculated
from the date of surgery to the last follow up visit. Any patient
with a follow up time of <6 weeks or with biological sling
placement was excluded from this study.Figure 1 Patient global impThe data analysed included pre-operative and post-opera-
tive daily pad usage, history of previous urethral disease or in-
sult (i.e. urethral stricture disease, brachytherapy, external
beam radiation therapy, etc.), urodynamic study (UDS) param-
eters, adverse events, and pre-operative presence of detrusor
overactivity (DO) as found on UDS prior to sling placement.
Each patient was asked to complete the validated patient global
impression of improvement (PGII), a seven-point Likert scale,
at each post-operative visit (Fig. 1) [6].
As a primary outcome, failure was defined as no change or
an increase in daily pad usage post-operatively. An improved
outcome was defined as greater than 50% improvement in dai-
ly pad usage post-operatively without having complete dry-
ness. Complete dryness required no pad usage. A successful
outcome was defined as complete dryness post-operatively or
improved condition.
Statistical analysis was performed using paired and two-
sample t-tests, chi-square, and logistical regression analysis
where appropriate. A p-value of <0.05 determined statistical
significance.
Results
A total of sixty-eight patients underwent male sling placement
from 2000 to 2011 by one surgeon. Thirty patients remained in
each group after exclusions. Eight total patients were excluded.
Five patients were excluded from the BAMS group for having
biological sling placement and three patients were excluded
from the TOMS group for inadequate follow up. The mean
age for the BAMS and TOMS groups were 68.9 years
(±10.80) and 70.4 years (±7.94), respectively Table 1. demon-
strates the pre-operative characteristics for each patient group.
The mean follow up time was 43.2 months (2–95) for the
BAMS group and 14.6 months (3–33) for the TOMS group
with statistically significant difference (p= 0.001). Pre-opera-
tively, only maximal urethral closure pressure (MUP) and ure-
thral insult demonstrated statistically significant difference
with p= 0.014 and p= 0.010, respectively.
When analysed, change in pad usage from pre- to post-
operatively was found to be significantly decreased in the
TOMS group from 3.5 pads per day to 1.5 pads per day
(p= 0.001) as compared to the BAMS group at 3.9 pads per
day to 3.5 pads per day (p= 0.747).
Upon analysis of pre-operative risk factors, urethral insult
(p= 0.001) and pre-operative pad use (p= 0.047) were the
only factors found to demonstrate significance and pre-dispose
patients to sling failure (Table 2).
Table 3 demonstrates the outcomes for each group.
Using our definition of failure, analysis revealed a failure
rate of 63.3% (19/30) in the BAMS group, compared toression of improvement.
Table 1 Pre-operative patient characteristics.a
BAMS (n= 30) TOMS (n= 30) p-Value
Age (years) 68.9 (39–84) 70.4 (54–86) 0.947
Follow-up (months) 43.2 (2–95) 14.6 (3–33) 0.001
Pad use 3.9 (1–10) 3.5 (1–12) 0.501
BMI 27.7 (21.11–39.43) 28.4 (21.44–37.56) 0.668
ALPP (cm H2O) 75.0 (5–150) 91.2 (22–152) 0.214
MUP (cm H2O) 64.8 (5–143) 99.4 (13–255) 0.014
FL (cm) 3.3 (1.5–6) 3.7 (2–7) 0.306
Urethral insult 19 (63.3%) 9 (30.0%) 0.010
DO 9 (30.0%) 7 (23.3%) 0.559
a BMI = body mass index, ALPP = leak point pressure, MUP=maximal urethral pressure, FL = functional
length, DO= detrusor overactivity.
Table 2 Pre-operative risk factors for sling failure.a
Risk factor p-Value
Age 0.180
BMI 0.339
Pre-operative pad use 0.047
ALPP 0.083
MUP 0.670
FL 0.627
Urethral insult 0.001
DO 0.094
a BMI = body mass index, ALPP = leak point pressure,
MUP=maximal urethral pressure, FL = functional
length, DO= detrusor overactivity.
SYNTHETIC SLINGS FOR MALE STRESS INCONTINENCE 13123.3% (7/30) in the TOMS group. Analysis of the PGI-I for
both groups as a whole after sling placement demonstrated a
mean of 3.64 in the BAMS group and 2.25 for the TOMS
group. This shows a statistically significant difference in fa-
vour of the TOMS group (p= 0.004). The trend in PGI-I
amongst the dry, improved, success, and failed groups is fur-
ther demonstrated in Table 3.
Of the patients who underwent BAMS, 22 (73%) patients
had an open prostatectomy with 14 of those 22 patients
(63.6%) having been failures and 8 of the 22 patients
(36.4%) either dry or improved. None (0%) of the BAMS
group underwent a laparoscopic prostatectomy, 3 (10%)
underwent an endoscopic prostatectomy, and 5 (17%) patient
charts contained no data regarding previous prostatectomy
procedure. In the TOMS group, 15 (50%) patients had an
open prostatectomy and only 3 (20%) were failures leaving
12 of the 15 patients (80%) as dry or improved. Eight (27%)
patients underwent prostatectomy by laparoscopic approach,
five (17%) underwent endoscopic approach, and two (7%)
patient charts contained no data regarding previous prostatec-
tomy procedure.
In our cohort of BAMS patients, three patients had bone
anchor dislodgement (10%) requiring revision, one patient
(3.3%) had no change in SUI after sling placement, one patient
(3.3%) had medication-refractory urgency with urge inconti-
nence effectively treated with sacral neuromodulation, and
three patients (10%) had scrotal/groyne pain or numbness that
resolved within three months. In the TOMS cohort, four
patients (13.3%) had post-operative acute urinary retention
that resolved with 3–5 days of catheter placement, one(3.3%) patient had recurrent SUI that was treated with a ure-
thral bulking agent, and four patients (13.3%) had post-oper-
ative scrotal/groyne pain or numbness that resolved within
three months.
Discussion
The treatment of post-prostatectomy incontinence (PPI) re-
mains a challenge for urologists. Not only must a surgeon con-
sider the most appropriate treatment modality for each
patient, but consideration must be given to patient motivation
and expectation of treatment. In some instances, the patient
may choose an AUS even with minor leakage secondary to
the desire to be completely dry. Therefore, thorough discussion
with each patient regarding treatment options and patient
expectation should not be underestimated.
Whilst this cohort demonstrates that the amount of pad
usage and urethral insult to be pre-disposing factors for sling
failure, our previous study demonstrated all analysed pre-oper-
ative risk factors to be significant for sling failure regardless of
the type of sling used [5]. Based on the results of both studies, it
seems that the most important risk factors to discuss with each
patient and consider prior to choosing a treatment modality is
the severity of pre-operative incontinence and the presence of
prior urethral insult.
Based on prior studies, severe pre-operative incontinence,
urodynamic proven detrusor instability, and treatment with
radiation therapy were predisposing factors for sling failure
in those receiving BAMS [7]. Our results mirror this study
and further conclude that these factors are predisposing not
just to BAMS failure but to TOMS failure as well. Of course,
the best case scenario for any patient would be minor pre-oper-
ative incontinence without the presence of urethral insult.
Whilst this is idealistic, the reality is that few patients present
with such optimal circumstances. Based on the results in this
study, favour is demonstrated by TOMS to be a better choice
when treating male SUI. However, these results may be sec-
ondary to a variety of factors and not just exclusively for rea-
sons of product superiority. It must be considered that there
may be a bias in favour of TOMS given the shorter follow
up interval.
To factor out material differences, all slings analysed were
of the synthetic variety. Therefore, questions of biologic mate-
rial failure are of no concern when considering superiority of
treatment outcomes. The only characteristics demonstrating
pre-operative significance were MUP and urethral insult.
Table 3 Group outcomes.a
Groups Dry Improved Success Failed
BAMS (n= 30) 4 (13.3%) 7 (23.3%) 11 (36.6%) 19 (63.3%)
TOMS (n= 30) 12 (40.0%) 11 (36.7%) 23 (76.7%) 7 (23.3%)
BAMS PGI-I (mean and SD) 1.75 (±0.83) 3.14 (±0.83) 2.64 (±1.12) 4.29 (±0.89)
TOMS PGI-I (mean and SD) 1.08 (±0.28) 2.32 (±0.86) 1.67 (±0.90) 4.14 (±0.35)
a BAMS= bone anchor male sling, TOMS= transobturator male sling, PGI-I = patient global impression of improvement, SD = standard
deviation.
132 Crites et al.Therefore, these factors may have had a bearing on treatment
outcome initially. Whilst demonstrating pre-operative signifi-
cance, MUP did not further demonstrate significance as a risk
factor for failure. Interestingly, those patients in the BAMS
group had lower pre-operative MUP values (64.8 cm H2O)
than did the TOMS group (99.4 cm H2O).
Sphincteric incompetence secondary to direct neurological
injury is the primary contributing factor to the development
to PPI [8,9]. Winters et al., found that >90% of males having
had radical prostatectomy by the retropubic approach had
sphincteric incompetence during UDS after surgery [10]. Since
MUP is a measure of external urethral sphincteric function,
one can be left with the inference that TOMS is better in patients
who have undergone radical prostatectomy by the open
approach or who have a lower MUP. This inference is
supported in our cohort by the analysis of the type of prostatec-
tomy procedures in the TOMS group. This better outcome may
be explained by the ability of a properly placed TOMS to better
support the external urethral sphincter through the design of the
mesh. A BAMS is tensioned by the surgeon to support the
urethra and can be limited. The configuration of the patient’s
bony pelvis with subsequent loose configuration of the sling
can render the BAMS as ineffective as if there were bone anchor
dislodgement. The TOMS applies tension directly to the bulbar
urethra and there remains a smaller window of error.
Many of the patients in this cohort had urethral insult sec-
ondary to neoadjuvant or adjuvant treatment with brachyther-
apy, external beam radiotherapy, cryotherapy, or urethral
insult through stricture disease. This may have also had a bear-
ing on the treatment outcomes with sling placements as these
are difficult parameters with which to deal. These findings
are further supported by previous studies demonstrating that
increased pre-operative incontinence and prior pelvic radiation
therapy negatively impacted treatment success with male slings
[5,11–13]. Whilst these treatment modalities can directly cause
scarring and strictures, they can also cause compromised blood
supply/fibrosis of the urethra, and decrease the tissue com-
pressibility of the urethra that inhibits coaptation of the exter-
nal sphincter. These inherent complications can make
treatment of any variety a challenge and may further explain
the success of the TOMS group alone. It goes without saying
that patients with more severe incontinence in the face of ure-
thral/sphincteric injury should be directed toward the place-
ment of an AUS.
We demonstrated an overall success rate of TOMS to show
a trend toward a better outcome than BAMS. This is supported
by the change in pad usage from pre to post-operatively. Of
those who had TOMS placement, 76.7% of patients experi-
enced total dryness or improvement versus only 36.7% of
BAMS. This directly contradicts a study reported by Schafferin which BAMS demonstrated 64% success rate of dry or im-
proved over 18 months follow up [12]. This is also in direct cor-
relation with the findings of our previous study comparing
BAMS and TOMS in which BAMS and TOMS demonstrated
a 31.7% and 69.6% success rate respectively [5]. In this cohort,
TOMS patients revealed significance in decrease in overall pad
usage post-operatively from 3.5 pads per day to 1.5 pads per
day. Disregarding the group outcome breakdown, the TOMS
group demonstrates an overall decrease in pad usage by half
as opposed to BAMS (3.9 pads per day to 3.5 pads per day).
This is further supported by a TOMS study that revealed a de-
crease in pad usage pre to post-operatively from 4.52 to 1.04 at
six months [14]. Although pad weight was not factored in, a
study by Cornel et al, demonstrated no significance when pad
weight was used [15]. Our patients were allowed to use their
own pads pre and post operatively and can infer a decrease in
pad weight with the reporting of less pad usage.
Even though our results demonstrate a trend toward a bet-
ter outcome of the TOMS group in the treatment of PPI, it is
reasonable to mention that technical differences and inherent
complications with each sling type exist. Whilst BAMS may
not demonstrate superiority in this or even other studies, there
are studies in which BAMS have a favourable and durable out-
come even with shorter follow up times [16]. However, BAMS
carry the inherent potential for bone anchor dislodgement that
may be responsible for failure both immediately and after
years of implantation [4,17]. This was seen in our cohort of
BAMS patients in 10% of patients. This should prompt pelvic
imaging if patients experience a return of symptoms. Con-
versely, TOMS carry the risk of proximal migrational patterns
and placement rendering it ineffective. Each type of sling car-
ries complication potentials that are similar. Each sling type
has the potential for erosion, infection, acute urinary retention,
recurrent SUI, urgency with urge incontinence, perineal/scro-
tal numbness, post-void dribbling, and persistent pain
[18–20]. Our results concerning adverse events do not differ
in the types. However, the adverse events experienced by our
patients were easily treatable and did not include infection or
sling erosion. Moreover, each patient should be thoroughly
counselled on the potential for complications both unique to
each sling type and those in common.
To further strengthen this retrospective study, patients
completed the PGI-I as is our protocol with any surgery. This
study demonstrates an overall significantly better satisfaction
rate with TOMS as is evidenced by an overall mean PGI-I of
2.25 versus 3.64 for the BAMS group (p= 0.004). This is com-
parable to a similar study by Crites et al., in which the PGI-I
was superior in the TOMS group [5]. In analysis of the PGI-I
trend with both groups, the PGI-I remained consistently stron-
ger with the TOMS group in all outcome arms. Keeping this in
1 Wadie, B. S.: Retropubic Bulbourethral Sling for Post-Prostatec-
tomy Male Incontinence: 2-Year Followup. J Urol.184, 2446-2451,
2010
2 Albo, M.E., Richter, H. E, Brubaker L. et al: Burch Colposus-
pension versus Fascial Sling to Reduce Urinary Stress Incontinence. N
Engl J Med. 356:2143-55, 2007.
SYNTHETIC SLINGS FOR MALE STRESS INCONTINENCE 133mind, the follow up time for each group was significantly dif-
ferent. Therefore, the PGI-I values for each group may have
differed if analysed at similar points in time.
The strengths of this study lie in the gathering of validated
PGI-I results to factor in patient satisfaction, the results of one
surgeon, and the ability to measure outcome based on com-
plete dryness, improvement, and frank failure. However, the
inherent weakness of this study lies in its retrospective nature,
the inequality of follow up time evaluated, and possibly im-
proved patient selection in the TOMS group.
Areas of further study would be to analyse the superiority
of sling types within the same group (i.e. different types of
TOMS), evaluation of sling outcomes based on patients having
had the same type of prostatectomy, and to further analyse
UDS parameters to determine potential factors for sling fail-
ure. Prospective, multi-centre studies of new male slings are
also critically needed to better evaluate their best role in treat-
ing male SUI.
Conclusions
TOMS demonstrates a trend toward better outcomes when
compared to BAMS, in a shorter follow up time, in patients
who have undergone any type of prostatectomy, and by pa-
tient satisfaction. Patients with pre-operative risk factors
such as severe incontinence or those who have had pelvic
radiation therapy, brachytherapy, or cryotherapy, with or
without concomitant urethral stricture disease, should be
counselled as to the likelihood of a poor outcome with
any type of male sling placement. These patients will be
more difficult to treat and may be more appropriate candi-
dates for AUS or urinary diversion.
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Editorial comment
The authors in this retrospective study have evaluated 2 types
of male slings: the perineal bone-anchored and transobturator.
Each arm comprised 30 patients. A point of strength in the
study was that all cases were performed by one surgeon.
Important to note: 73% of those having bone-anchored and
50% of those with transobturator slings had open prostatecto-
my, presumably for symptomatic BPH.
However, what is more important is the conclusion the
authors made that Transobturator route is better than bone
anchored one, regarding cure of incontinence as a primary out-
come measure.
Looking at table 1, the length of follow up is significantly
different. Those with transobturator tapes were seen much ear-
lier than those with bone anchored slings (14.6 months vs.
43.2 months).
Urethral function was considered poorer in those with the
bone-anchored sling. Maximum urethral pressure was signifi-
cantly lower than transobturator slings. 19 patients in the
bone-anchored group were having urethral damage (stricture,
irradiation...). This is much higher than the comparable group
in the bone-anchored arm (9 only).
It is well documented in the literature that success rate of
male slings1; like female slings2; is inversely proportional to
134 Crites et al.time. Cure rate with such devices usually follows a de- cre-
scendo pattern. This intuitively means that a sling performs
better at shorter follow up without being truly superior.
Urethral function in the group of bone-anchored slings was
significantly worse than in the transobturator group and this
also implies that the latter may do better just because of the
better urethra it is applied to.
Based on these facts, I feel the difference of cure/improve-
ment between the 2 slings subject mater of the study is not
truly significant and I would rather stick to the Null hypothe-sis: the difference between the 2 slings might be entirely attrib-
uted to chance!
Bassem S. Wadie, MSc, MD,
Professor of Urology,
Voiding dysfunction and Incontinence unit,
Urology and Nephrology Center,
Mansoura University,
Mansoura, Egypt.
